Brought to you by 
10x Genomics gets $50mm in Series D funds, secures $75mm in debt facility
23 Jan 2020
Executive Summary
10x Genomics Inc. (genomic discovery) raised $50mm in a Series D financing led by Meritech Capital Partners, which was joined by first-time backer Wells Fargo Strategic Capital and returning shareholders Paladin Capital, Fidelity, and the SoftBank Group. The company also secured a $75mm credit facility with Silicon Valley Bank. 10x will use the proceeds for ongoing product development, global commercialization activities, and expansion of its internal manufacturing operations.
Deal Industry
- Research, Analytical Equipment & Supplies
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Nonconvertible Debt
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
10x Genomics gets $50mm in Series D funds, secures $75mm in debt facility
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice